Baillie Gifford - Q1 2021 holdings

$179 Billion is the total value of Baillie Gifford's 1100 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was - .

 Value Shares↓ Weighting
CPNG NewCoupangcl a$1,088,366,00022,054,023
+100.0%
0.61%
BNTX NewBioNTech ADRspons ads$735,723,0006,738,012
+100.0%
0.41%
AFRM NewAffirm Holdings Inc Class B - converted at IPO$578,486,0008,179,944
+100.0%
0.32%
IAC NewIac/Interactivecorp$359,110,0001,660,165
+100.0%
0.20%
SANA NewSana Biotechnology Inc - converted at IPO$334,284,0009,987,545
+100.0%
0.19%
OSCR NewOscar Health Inc - converted at IPO$329,682,00012,264,921
+100.0%
0.18%
LI NewLi Auto ADRspons ads$229,404,0009,176,168
+100.0%
0.13%
COUR NewCoursera Inc$148,011,0003,289,132
+100.0%
0.08%
CHPT NewChargePoint Holdings Inc$106,800,0004,000,000
+100.0%
0.06%
PLD NewPrologis Inc REIT$63,547,000599,500
+100.0%
0.04%
REXR NewRexford Industrial Realty REIT$61,710,0001,224,400
+100.0%
0.04%
DRE NewDuke Realty Corporation REIT$57,418,0001,369,380
+100.0%
0.03%
FROG NewJFROG Ltd$50,985,0001,149,102
+100.0%
0.03%
CDLX NewCardlytics Inc$48,890,000445,677
+100.0%
0.03%
FR NewFirst Industrial REIT$47,965,0001,047,512
+100.0%
0.03%
CLOV NewClover Health Investments Corp$38,875,0005,142,177
+100.0%
0.02%
ABCL NewAbcellera Biologics Inc$39,235,0001,155,353
+100.0%
0.02%
QTRX NewQuanterix Corp$30,054,000514,012
+100.0%
0.02%
BMBL NewBumble Inc$24,952,000400,000
+100.0%
0.01%
BFLY NewButterfly Network Inc$21,631,0001,285,209
+100.0%
0.01%
CERT NewCertara$21,498,000787,464
+100.0%
0.01%
NewDocebo$1,298,00030,200
+100.0%
0.00%
AMKR NewAmkor Technology$54,0002,282
+100.0%
0.00%
BPMC NewBlueprint Medicines Corp$41,000426
+100.0%
0.00%
AI NewC3.aicl a$8,000117
+100.0%
0.00%
CSOD NewCornerstone Ondemand Inc$45,0001,043
+100.0%
0.00%
DCT NewDuck Creek Technologies$16,000355
+100.0%
0.00%
JAGX NewJaguar Health - US indemnity shares$02,033,592
+100.0%
0.00%
MED NewMedifast Inc$28,000134
+100.0%
0.00%
EGOV NewNic Inc$27,000800
+100.0%
0.00%
NNDM NewNano Dimension ADRspons ads$14,0001,600
+100.0%
0.00%
OPK NewOpko Health Inc$31,0007,300
+100.0%
0.00%
PS NewPluralsight$44,0001,972
+100.0%
0.00%
SEER NewSeer$11,000223
+100.0%
0.00%
TMDX NewTransMedics Group$17,000400
+100.0%
0.00%
VUZI NewVuzix$25,0001,000
+100.0%
0.00%
VYNE NewVyne Therapeutics Inc$676,00098,762
+100.0%
0.00%
ALKS NewAlkermes Plc$4,000192
+100.0%
0.00%
DOX NewAmdocs$28,000400
+100.0%
0.00%
GAN NewGAN$10,000572
+100.0%
0.00%
CGNT NewCognyte Software$8,000303
+100.0%
0.00%
FVRR NewFiverr Intl$22,000100
+100.0%
0.00%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-06
Signatures

The EDGAR filing(s) were signed by:

About Baillie Gifford

Baillie Gifford is a well-known investment management firm that has been in operation for over a century. The company was founded in 1908 and is headquartered in Edinburgh, Scotland. Baillie Gifford has a reputation for being a long-term investor, with a focus on growth-oriented companies. The firm manages a range of investment strategies, including equities, fixed income, and multi-asset portfolios.

Baillie Gifford has a team of experienced investment professionals, including its CEO, Andrew Telfer, and its Chief Investment Officer, Charles Plowden. The firm's investment philosophy is based on the belief that long-term investing is the best way to achieve superior returns. Baillie Gifford's investment process involves in-depth research and analysis of companies, with a focus on identifying those with strong growth potential.

One of the key strengths of Baillie Gifford is its focus on innovation. The firm has a history of investing in companies that are disrupting traditional industries, such as Tesla and Amazon. Baillie Gifford also has a strong track record of investing in emerging markets, such as China and India.

Overall, Baillie Gifford is a respected investment management firm with a long history of delivering strong returns for its clients. The firm's focus on long-term investing and innovation has helped it to stand out in a crowded market, and its experienced team of investment professionals is well-equipped to navigate the challenges of today's investment landscape.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Amazon.Com42Q3 202310.0%
Tesla Motors42Q3 202310.7%
Illumina42Q3 20236.6%
Baidu.com Sponsored ADR42Q3 202311.6%
Meta Platforms Inc42Q3 20235.0%
MercadoLibre42Q3 20237.3%
Intuitive Surgical42Q3 20233.5%
Moody's Corp42Q3 20231.4%
MasterCard Inc-Class A42Q3 20231.9%
Workday Inc42Q3 20231.4%

View Baillie Gifford's complete holdings history.

Latest significant ownerships (13-D/G)
Baillie Gifford Q1 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Oddity Tech LtdSeptember 07, 20234,914,66110.9%
Roblox CorpSeptember 07, 202328,106,2155.0%
SiteOne Landscape Supply, Inc.August 03, 20232,234,9855.0%
UPWORK, INCAugust 03, 20236,565,2304.9%
CHINOOK THERAPEUTICS, INC.August 01, 2023844,6842.0%
MELI Kaszek Pioneer CorpSold outJuly 05, 202300.0%
Abcam plcJune 08, 202311,331,7264.9%
CARVANA CO.June 06, 202361,9890.1%
EverQuote, Inc.May 03, 20231,358,4395.0%
CEMEX SAB DE CVMarch 03, 2023752,914,1105.0%

View Baillie Gifford's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-04-04
SC 13G/A2024-04-04
SC 13G/A2024-03-07
SC 13G/A2024-03-06
SC 13G/A2024-02-07
SC 13G/A2024-02-01
SC 13G/A2024-02-01
SC 13G/A2024-01-30
SC 13G/A2024-01-30
SC 13G/A2024-01-30

View Baillie Gifford's complete filings history.

Compare quarters

Export Baillie Gifford's holdings